Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.
Industry, Sector and Symbol
Industry Testing laboratories
Sub-IndustryN/A
SectorMedical
Phone561-855-1626
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.62 million
Profitability
Miscellaneous
Employees155
OptionableNot Optionable
Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions
What is Rennova Health's stock symbol?
Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."
When did Rennova Health's stock split? How did Rennova Health's stock split work?
Rennova Health shares reverse split on the morning of Monday, November 12th 2018. The 1-500 reverse split was announced on Thursday, November 8th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 9th 2018. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.
How were Rennova Health's earnings last quarter?
Rennova Health Inc (OTCMKTS:RNVA) released its earnings results on Thursday, November, 15th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $5.04 million for the quarter. Rennova Health had a net margin of 93.58% and a negative return on equity of 14.10%. View Rennova Health's Earnings History.
When is Rennova Health's next earnings date?
Has Rennova Health been receiving favorable news coverage?
Media stories about RNVA stock have been trending very positive recently, InfoTrie reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rennova Health earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are some of Rennova Health's key competitors?
Some companies that are related to Rennova Health include 22nd Century Group (XXII), 3D Signatures (DXD), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abaxis (ABAX), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acerus Pharmaceuticals (ASP), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW) and Activecare (ACAR).
Who are Rennova Health's key executives?
Rennova Health's management team includes the folowing people:
- Mr. Seamus Lagan, Pres, CEO & Director (Age 50)
- Ms. Marlene McLennan, Chief Financial Officer
- Mr. David Cope, Interim Compliance Officer
- Ms. Karen Taylor, Director of HR
- Mr. Albert F. Lechner, Exec. VP of Sales - Rennova Health Technology Solutions
How do I buy shares of Rennova Health?
Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rennova Health's stock price today?
One share of RNVA stock can currently be purchased for approximately $0.0008.
How big of a company is Rennova Health?
Rennova Health has a market capitalization of $3,415.20 and generates $4.62 million in revenue each year. Rennova Health employs 155 workers across the globe.
What is Rennova Health's official website?
How can I contact Rennova Health?
Rennova Health's mailing address is 400 S. Australian Avenue 8th Floor, West Palm Beach FL, 33401. The company can be reached via phone at 561-855-1626 or via email at [email protected]
MarketBeat Community Rating for Rennova Health (OTCMKTS RNVA)
MarketBeat's community ratings are surveys of what our community members think about Rennova Health and other stocks. Vote "Outperform" if you believe RNVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RNVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
